Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MYNDF market cap is 2.72M. The company's latest EPS is CAD -0.0317 and P/E is -1.89.
| Year End 31 October 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -15k | -3.39M | -1.95M | -1.18M |
| Net Income | -25k | -4.37M | -3.57M | -1.52M |
| Year End 31 October 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 170k | 2.67M | 654k | 797k |
| Total Liabilities | 197k | 2.74M | 4.19M | 5.77M |
| Total Equity | -27k | -68k | -3.53M | -4.98M |
| Year End 31 October 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | N/A | -2.98M | -1.82M | -198k |
| Investing | N/A | 2.13M | -81k | 198k |
| Financing | N/A | 2.75M | N/A | N/A |
| Market Cap | 2.72M |
| Price to Earnings Ratio | -1.89 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -0.58 |
| Dividend Yield | - |
| Shares Outstanding | 47.82M |
| Average Volume (1 week) | 700 |
| Average Volume (1 Month) | 2.97k |
| 52 Week Change | 135.61% |
| 52 Week High | 0.0675 |
| 52 Week Low | 0.0125 |
| Spread (Intraday) | 0.54 (97.74%) |
| Company Name | MYND Life Sciences Inc (QB) |
| Address |
700 9 avenue, sw, #3000 vancouver, british columbia T2P 3V4 |
| Website | https://www.myndsciences.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
